News & Updates
7 unreadGP communications, portfolio company news & market insights
Private Markets Q1 Outlook: Buyout Multiples Compress
Our quarterly analysis shows buyout entry multiples declining to 10.2x EV/EBITDA from 11.8x in Q4 2025, creating attractive deployment opportunities.
Series D Close — $180M at $2.1B valuation
Arcadia Health closed its Series D round at a $2.1B valuation, representing significant markup for Fund IV investors.
Q1 2026 GP Letter — Palisade Real Estate II
Dear Limited Partners, please find our quarterly update covering portfolio performance and market conditions.
Q1 2026 GP Letter — Meridian Buyout Fund IV
Dear Limited Partners, we are pleased to share our quarterly update...
NovaTech Series C — $95M at $780M Valuation
NovaTech closed its Series C round, bringing the total raised to $185M. The company plans to expand into the European semiconductor market.
Bolt-on Acquisition: Structura ($45M)
Palisade Real Estate II has completed a bolt-on acquisition of Structura for $45M.
NovaBuild Secures $320M Government Contract
NovaBuild has been awarded a $320M modular construction contract for federal housing infrastructure.
ESG Integration: New SEC Climate Disclosure Rules
Analysis of the final SEC climate disclosure rules and implications for PE fund reporting requirements effective 2027.
Q4 Revenue Miss — Growth Decelerated to 18% YoY
DataForge reported Q4 revenue growth of 18% YoY, below the 25% consensus estimate.
NeuroLink FDA Breakthrough Therapy Designation
NeuroLink received FDA Breakthrough Therapy Designation for its neural interface platform targeting treatment-resistant depression.
New CFO Appointed from Stripe
ClearPay announced the appointment of a new CFO, previously VP Finance at Stripe.
Q4 2025 GP Letter — Apex Growth Fund III
Dear Limited Partners, we present our Q4 update highlighting portfolio developments and strategic outlook.
Palisade Secondaries I — Deployment Update
The fund has deployed 37% of committed capital across 12 LP-led transactions.
CloudVault: Strategic Review Initiated
The board has initiated a strategic review process, exploring options including a potential sale or recapitalization.
Refinancing Completed at L+325
Successfully refinanced the senior facility at L+325, down from L+400.
Secondary Market Pricing Trends — February 2026
LP-led secondary pricing averaged 91% of NAV in February, up from 88% in November 2025, reflecting improved market sentiment.
TerraCore Exit Complete — 2.8x MOIC Realized
Meridian Capital has completed the exit of TerraCore via sale to a strategic acquirer, realizing a 2.8x MOIC for Fund IV investors.
Apex Late Stage VI — ESG Impact Report Published
Our annual ESG impact report details carbon reduction metrics, diversity initiatives, and governance improvements across the portfolio.
By Type
By Fund
Recent Highlights
Series D Close — $180M at $2.1B valuation
Meridian Capital · Mar 15, 2026
NovaTech Series C — $95M at $780M Valuation
Apex Venture Partners · Mar 12, 2026
NovaBuild Secures $320M Government Contract
Meridian Capital · Mar 10, 2026
Platform Insights
Market commentary & research from Locke 27Private Markets Q1 Outlook: Buyout Multiples Compress
Locke 27 Research
Our quarterly analysis shows buyout entry multiples declining to 10.2x EV/EBITDA from 11.8x in Q4 2025, creating attractive deployment opportunities.
ESG Integration: New SEC Climate Disclosure Rules
Locke 27 Research
Analysis of the final SEC climate disclosure rules and implications for PE fund reporting requirements effective 2027.
Secondary Market Pricing Trends — February 2026
Locke 27 Research
LP-led secondary pricing averaged 91% of NAV in February, up from 88% in November 2025, reflecting improved market sentiment.